{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:57:03Z","timestamp":1789786623792,"version":"4.0.1"},"reference-count":223,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2014,7,11]],"date-time":"2014-07-11T00:00:00Z","timestamp":1405036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI060561"],"award-info":[{"award-number":["R01AI060561"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI089957"],"award-info":[{"award-number":["R01AI089957"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Despite the development of potent antiviral drugs, HCV remains a global health problem; global eradication is a long way off. In this review, we discuss the immune response to HCV infection and particularly, the interplay between viral strategies that delay the onset of antiviral responses and host strategies that limit or even eradicate infected cells but also contribute to pathogenesis. Although HCV can disable some cellular virus-sensing machinery, IFN-stimulated antiviral genes are induced in the infected liver. Whereas epitope evolution contributes to escape from T cell-mediated immunity, chronic high antigen load may also blunt the T cell response by activating exhaustion or tolerance mechanisms. The evasive maneuvers of HCV limit sterilizing humoral immunity through rapid evolution of decoy epitopes, epitope masking, stimulation of interfering antibodies, lipid shielding, and cell-to-cell spread. Whereas the majority of HCV infections progress to chronic hepatitis with persistent viremia, at least 20% of patients spontaneously clear the infection. Most of these are protected from reinfection, suggesting that protective immunity to HCV exists and that a prophylactic vaccine may be an achievable goal. It is therefore important that we understand the correlates of protective immunity and mechanisms of viral persistence.<\/jats:p>","DOI":"10.1189\/jlb.4ri0214-126r","type":"journal-article","created":{"date-parts":[[2014,7,12]],"date-time":"2014-07-12T06:09:40Z","timestamp":1405145380000},"page":"535-548","source":"Crossref","is-referenced-by-count":41,"title":["Immune control and failure in HCV infection\u2014tipping the balance"],"prefix":"10.1093","volume":"96","author":[{"given":"Lynn B","family":"Dustin","sequence":"first","affiliation":[{"name":"University of Oxford, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, Kennedy Institute of Rheumatology , Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobh\u00e1n B","family":"Cashman","sequence":"additional","affiliation":[{"name":"University of Oxford, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, Kennedy Institute of Rheumatology , Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M","family":"Laidlaw","sequence":"additional","affiliation":[{"name":"University of Oxford, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, Kennedy Institute of Rheumatology , Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,7,11]]},"reference":[{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrgastro.2013.107","article-title":"Epidemiology and natural history of HCV infection","volume":"10","author":"Hajarizadeh","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1469-0691.2010.03432.x","article-title":"Evolving epidemiology of hepatitis C virus","volume":"17","author":"Lavanchy","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"Mohd Hanafiah","year":"2013","journal-title":"Hepatology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1478-3231.2008.01927.x","article-title":"The history of the \u201cnatural history\u201d of hepatitis C (1968\u20132009)","volume":"29","author":"Seeff","year":"2009","journal-title":"Liver Int."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/0003-4819-156-4-201202210-00004","article-title":"The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007","volume":"156","author":"Ly","year":"2012","journal-title":"Ann. Intern. Med."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/cid\/cit642","article-title":"Causes of death and characteristics of decedents with viral hepatitis, United States, 2010","volume":"58","author":"Ly","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1758-2652-14-22","article-title":"Hepatitis C in HIV-infected individuals: cure and control, right now","volume":"14","author":"Thomas","year":"2011","journal-title":"J. Int. AIDS Soc."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1517\/14656566.2014.913571","article-title":"Advances in the treatment of hepatitis B virus\/hepatitis C virus coinfection","volume":"15","author":"Sagnelli","year":"2014","journal-title":"Expert Opin. Pharmacother."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1034\/j.1600-0676.2000.020004281.x","article-title":"Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C co-infected with","volume":"20","author":"Kamal","year":"2000","journal-title":"S. mansoni Liver"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nrd4036","article-title":"All-oral HCV therapies near approval","volume":"12","author":"Tse","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/hep.23220","article-title":"Public health impact of antiviral therapy for hepatitis C in the United States","volume":"50","author":"Volk","year":"2009","journal-title":"Hepatology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/nm.3184","article-title":"Global control of hepatitis C: where challenge meets opportunity","volume":"19","author":"Thomas","year":"2013","journal-title":"Nat. Med."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/hep.26590","article-title":"Expanding access to hepatitis C virus care: a call to deconstruct individualized therapy","volume":"59","author":"Aronsohn","year":"2013","journal-title":"Hepatology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nm.3183","article-title":"Current progress in development of hepatitis C virus vaccines","volume":"19","author":"Liang","year":"2013","journal-title":"Nat. Med."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.26744","article-title":"Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource","volume":"59","author":"Smith","year":"2014","journal-title":"Hepatology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrmicro1645","article-title":"Replication of hepatitis C virus","volume":"5","author":"Moradpour","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm.3248","article-title":"Understanding the hepatitis C virus life cycle paves the way for highly effective therapies","volume":"19","author":"Scheel","year":"2013","journal-title":"Nat. Med."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrmicro3046","article-title":"The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection","volume":"11","author":"Bartenschlager","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.coviro.2011.05.017","article-title":"Lipoprotein component associated with hepatitis C virus is essential for virus infectivity","volume":"1","author":"Shimizu","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrmicro3098","article-title":"The ins and outs of hepatitis C virus entry and assembly","volume":"11","author":"Lindenbach","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/hep.26770","article-title":"Simultaneous detection of hepatitis C virus and interferon stimulated gene expression in infected human liver","volume":"59","author":"Wieland","year":"2014","journal-title":"Hepatology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1600-065X.2008.00731.x","article-title":"Pattern recognition receptors and control of adaptive immunity","volume":"227","author":"Palm","year":"2009","journal-title":"Immunol. Rev."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/nm.3253","article-title":"Regulation of hepatic innate immunity by hepatitis C virus","volume":"19","author":"Horner","year":"2013","journal-title":"Nat. Med."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00281-012-0332-x","article-title":"Innate immune responses in hepatitis C virus infection","volume":"35","author":"Li","year":"2013","journal-title":"Semin. Immunopathol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1002\/hep.20239","article-title":"Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees","volume":"39","author":"Major","year":"2004","journal-title":"Hepatology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1053\/j.gastro.2005.01.049","article-title":"Mathematical modeling of primary hepatitis C infection: noncytolytic clearance and early blockage of virion production","volume":"128","author":"Dahari","year":"2005","journal-title":"Gastroenterology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1128\/JVI.75.15.7059-7066.2001","article-title":"DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection","volume":"75","author":"Bigger","year":"2001","journal-title":"J. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"15669","DOI":"10.1073\/pnas.202608199","article-title":"Genomic analysis of the host response to hepatitis C virus infection","volume":"99","author":"Su","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"15661","DOI":"10.1073\/pnas.202608299","article-title":"Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease","volume":"99","author":"Thimme","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/B978-0-12-410524-9.00004-9","article-title":"Intracellular pathogen detection by RIG-I-like receptors","volume":"117","author":"Dixit","year":"2013","journal-title":"Adv. Immunol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.molcel.2007.10.032","article-title":"The C-terminal regulatory domain is the RNA 5\u2032-triphosphate sensor of RIG-I","volume":"29","author":"Cui","year":"2008","journal-title":"Mol. Cell"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature07106","article-title":"Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA","volume":"454","author":"Saito","year":"2008","journal-title":"Nature"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1128\/JVI.02449-08","article-title":"Nucleotide sequences and modifications that determine RIG-I\/RNA binding and signaling activities","volume":"83","author":"Uzri","year":"2009","journal-title":"J. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/nature05732","article-title":"TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity","volume":"446","author":"Gack","year":"2007","journal-title":"Nature"},{"key":"2023032708372924700_","first-page":"e00785","article-title":"MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades","volume":"2","author":"Liu","year":"2013","journal-title":"Elfe"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/embr.201338025","article-title":"Ubiquitin in the immune system","volume":"15","author":"Zinngrebe","year":"2014","journal-title":"EMBO Rep."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nature04193","article-title":"Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus","volume":"437","author":"Meylan","year":"2005","journal-title":"Nature"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"17717","DOI":"10.1073\/pnas.0508531102","article-title":"Hepatitis C virus protease NS3\/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity","volume":"102","author":"Li","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/hep.23426","article-title":"Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system","volume":"51","author":"Bellecave","year":"2010","journal-title":"Hepatology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.1073\/pnas.0601523103","article-title":"Viral and therapeutic control of IFN-\u03b2 promoter stimulator 1 during hepatitis C virus infection","volume":"103","author":"Loo","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.chom.2013.01.012","article-title":"Incoming RNA virus nucleocapsids containing a 5\u2032-triphosphorylated genome activate RIG-I and antiviral signaling","volume":"13","author":"Weber","year":"2013","journal-title":"Cell Host Microbe"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.antiviral.2009.05.004","article-title":"Translational insensitivity to potent activation of PKR by HCV IRES RNA","volume":"83","author":"Shimoike","year":"2009","journal-title":"Antiviral Res."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"e1002289","DOI":"10.1371\/journal.ppat.1002289","article-title":"Hepatitis C virus reveals a novel early control in acute immune response","volume":"7","author":"Arnaud","year":"2011","journal-title":"PLoS Pathog."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.chom.2009.11.004","article-title":"Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation","volume":"6","author":"Garaigorta","year":"2009","journal-title":"Cell Host Microbe"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1053\/j.gastro.2005.01.059","article-title":"Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection","volume":"128","author":"Chen","year":"2005","journal-title":"Gastroenterology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1099\/vir.0.015388-0","article-title":"ISG15, a ubiquitin-like interferon-stimulated gene, promotes hepatitis C virus production in vitro: implications for chronic infection and response to treatment","volume":"91","author":"Chen","year":"2010","journal-title":"J. Gen. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1073\/pnas.0408824102","article-title":"Immune evasion by hepatitis C virus NS3\/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF","volume":"102","author":"Li","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023032708372924700_","first-page":"219","article-title":"Innate immune responses to hepatitis C virus","volume":"369","author":"Schoggins","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-\u03bbs mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat. Immunol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","author":"Prokunina-Olsson","year":"2013","journal-title":"Nat. Genet."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"7431","DOI":"10.1073\/pnas.1002301107","article-title":"Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection","volume":"107","author":"Takahashi","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.chom.2012.08.010","article-title":"Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity","volume":"12","author":"Dreux","year":"2012","journal-title":"Cell Host Microbe"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"e1003316","DOI":"10.1371\/journal.ppat.1003316","article-title":"Hepatitis C virus pathogen associated molecular pattern (PAMP) triggers production of \u03bb-interferons by human plasmacytoid dendritic cells","volume":"9","author":"Stone","year":"2013","journal-title":"PLoS Pathog."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1002\/hep.24580","article-title":"Hepatitis C virus induces interferon-\u03bb and interferon-stimulated genes in primary liver cultures","volume":"54","author":"Marukian","year":"2011","journal-title":"Hepatology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/hep.25897","article-title":"IL-29 is the dominant type III interferon produced by hepatocytes during acute hepatitis C virus infection","volume":"56","author":"Park","year":"2012","journal-title":"Hepatology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1053\/j.gastro.2011.12.055","article-title":"HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons","volume":"142","author":"Thomas","year":"2012","journal-title":"Gastroenterology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.chom.2014.01.007","article-title":"Interferon \u03bb alleles predict innate antiviral immune responses and hepatitis C virus permissiveness","volume":"15","author":"Sheahan","year":"2014","journal-title":"Cell Host Microbe"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/hep.24557","article-title":"Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells","volume":"54","author":"Andrus","year":"2011","journal-title":"Hepatology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1053\/j.gastro.2006.09.052","article-title":"Interferons \u03b1 and \u03bb inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics","volume":"131","author":"Marcello","year":"2006","journal-title":"Gastroenterology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1128\/JVI.79.6.3851-3854.2005","article-title":"\u03bb Interferon inhibits hepatitis B and C virus replication","volume":"79","author":"Robek","year":"2005","journal-title":"J. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.coviro.2011.10.008","article-title":"Interferon-stimulated genes and their antiviral effector functions","volume":"1","author":"Schoggins","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.jhep.2013.07.033","article-title":"Interferon-stimulated genes and their role in controlling hepatitis C virus","volume":"59","author":"Metz","year":"2013","journal-title":"J. Hepatol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/hep.26653","article-title":"Kinetic differences in the induction of interferon stimulated genes by interferon-\u03b1 and interleukin 28B are altered by infection with hepatitis C virus","volume":"59","author":"Jilg","year":"2014","journal-title":"Hepatology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature09907","article-title":"A diverse range of gene products are effectors of the type I interferon antiviral response","volume":"472","author":"Schoggins","year":"2011","journal-title":"Nature"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"7034","DOI":"10.1073\/pnas.0707882105","article-title":"Interferon signaling and treatment outcome in chronic hepatitis C","volume":"105","author":"Sarasin-Filipowicz","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1002\/hep.23912","article-title":"IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C","volume":"52","author":"Urban","year":"2010","journal-title":"Hepatology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1053\/j.gastro.2012.04.018","article-title":"Persistence of HCV in quiescent hepatic cells under conditions of an interferon-induced antiviral response","volume":"143","author":"Bauhofer","year":"2012","journal-title":"Gastroenterology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1053\/j.gastro.2013.08.034","article-title":"Use of laser capture microdissection to map hepatitis C virus-positive hepatocytes in human liver","volume":"145","author":"Kandathil","year":"2013","journal-title":"Gastroenterology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2893.2007.00921.x","article-title":"Antiviral therapy: chronic hepatitis C","volume":"14","author":"Heathcote","year":"2007","journal-title":"J. Viral. Hepat."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1172\/JCI45610","article-title":"Chemokine antagonism in chronic hepatitis C virus infection","volume":"121","author":"Charles","year":"2011","journal-title":"J. Clin. Invest."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon-\u03b1 and ribavirin therapy","volume":"41","author":"Suppiah","year":"2009","journal-title":"Nat. Genet."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-\u03b1 and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat. Genet."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/infdis\/jit433","article-title":"Association of the IFNL4-\u0394G allele with impaired spontaneous clearance of hepatitis C virus","volume":"209","author":"Aka","year":"2014","journal-title":"J. Infect. Dis."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1093\/infdis\/jiu016","article-title":"Lymphocytes degranulation in liver in hepatitis C virus carriers is associated with IFNL4 polymorphisms and ALT levels","volume":"209","author":"Jouvin-Marche","year":"2014","journal-title":"J. Infect. Dis."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"e84026","DOI":"10.1371\/journal.pone.0084026","article-title":"Interferon-\u03bb4 (IFNL4) transcript expression in human liver tissue samples","volume":"8","author":"Amanzada","year":"2013","journal-title":"PLoS One"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1002\/hep.21060","article-title":"The liver as an immunological organ","volume":"43","author":"Racanelli","year":"2006","journal-title":"Hepatology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/gut.2010.212555","article-title":"Natural killer cells and hepatitis C: action and reaction","volume":"60","author":"Cheent","year":"2011","journal-title":"Gut"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-020711-075005","article-title":"Controlling natural killer cell responses: integration of signals for activation and inhibition","volume":"31","author":"Long","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.1097670","article-title":"HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection","volume":"305","author":"Khakoo","year":"2004","journal-title":"Science"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/hep.23477","article-title":"Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus","volume":"51","author":"Knapp","year":"2010","journal-title":"Hepatology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev.immunol.25.022106.141602","article-title":"Flying under the radar: the immunobiology of hepatitis C","volume":"25","author":"Dustin","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1053\/j.gastro.2010.01.006","article-title":"Activation of natural killer cells during acute infection with hepatitis C virus","volume":"138","author":"Amadei","year":"2010","journal-title":"Gastroenterology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jhep.2010.05.013","article-title":"Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responses","volume":"53","author":"Pelletier","year":"2010","journal-title":"J. Hepatol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep.22624","article-title":"Natural killer cell function is intact after direct exposure to infectious hepatitis C virions","volume":"49","author":"Yoon","year":"2009","journal-title":"Hepatology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/hep.24628","article-title":"Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients","volume":"55","author":"Edlich","year":"2012","journal-title":"Hepatology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/imr.12090","article-title":"Natural killer cells: multifaceted players with key roles in hepatitis C immunity","volume":"255","author":"Golden-Mason","year":"2013","journal-title":"Immunol. Rev."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1053\/j.gastro.2010.01.051","article-title":"Interferon-\u03b1-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection","volume":"138","author":"Stegmann","year":"2010","journal-title":"Gastroenterology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1172\/JCI39133","article-title":"Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence","volume":"119","author":"Rehermann","year":"2009","journal-title":"J. Clin. Invest."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nm.3251","article-title":"Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells","volume":"19","author":"Rehermann","year":"2013","journal-title":"Nat. Med."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"12584","DOI":"10.1128\/JVI.76.24.12584-12595.2002","article-title":"Broad specificity of virus-specific CD4+ T-helper-cell responses in resolved hepatitis C virus infection","volume":"76","author":"Day","year":"2002","journal-title":"J. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1126\/science.1088774","article-title":"HCV persistence and immune evasion in the absence of memory T cell help","volume":"302","author":"Grakoui","year":"2003","journal-title":"Science"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1084\/jem.20030239","article-title":"Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection","volume":"197","author":"Shoukry","year":"2003","journal-title":"J. Exp. Med."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1053\/j.gastro.2008.12.034","article-title":"Analysis of CD8+ T-cell-mediated inhibition of hepatitis C virus replication using a novel immunological model","volume":"136","author":"Jo","year":"2009","journal-title":"Gastroenterology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2893.2009.01172.x","article-title":"Clearance of hepatitis C in chimpanzees is associated with intrahepatic T-cell perforin expression during the late acute phase","volume":"17","author":"Watanabe","year":"2010","journal-title":"J. Viral. Hepat."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat. Immunol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0140-6736(02)08435-0","article-title":"Protection against persistence of hepatitis C","volume":"359","author":"Mehta","year":"2002","journal-title":"Lancet"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1128\/JVI.78.3.1575-1581.2004","article-title":"Cross-genotype immunity to hepatitis C virus","volume":"78","author":"Lanford","year":"2004","journal-title":"J. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"8183","DOI":"10.1128\/JVI.00142-08","article-title":"Previously infected chimpanzees are not consistently protected against reinfection or persistent infection after reexposure to the identical hepatitis C virus strain","volume":"82","author":"Bukh","year":"2008","journal-title":"J. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1126\/science.1279801","article-title":"Lack of protective immunity against reinfection with hepatitis C virus","volume":"258","author":"Farci","year":"1992","journal-title":"Science"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1182\/blood-2007-01-069583","article-title":"Immunologic evidence for lack of heterologous protection following resolution of HCV in patients with nongenotype 1 infection","volume":"110","author":"Schulze Zur Wiesch","year":"2007","journal-title":"Blood"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1038\/nm.3408","article-title":"Subinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection","volume":"19","author":"Park","year":"2013","journal-title":"Nat. Med."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1084\/jem.194.10.1395","article-title":"Determinants of viral clearance and persistence during acute hepatitis C virus infection","volume":"194","author":"Thimme","year":"2001","journal-title":"J. Exp. Med."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1136\/gutjnl-2011-300620","article-title":"T cell responses in hepatitis C: the good, the bad and the unconventional","volume":"61","author":"Klenerman","year":"2012","journal-title":"Gut"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.pathol.1.110304.100230","article-title":"Imunobiology and pathogenesis of viral hepatitis","volume":"1","author":"Guidotti","year":"2006","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1084\/jem.194.12.1755","article-title":"Blocking chemokine responsive to \u03b3-2\/interferon (IFN)-\u03b3 inducible protein and monokine induced by IFN-\u03b3 activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes","volume":"194","author":"Kakimi","year":"2001","journal-title":"J. Exp. Med."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/infdis\/jir835","article-title":"Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion","volume":"205","author":"Raghuraman","year":"2012","journal-title":"J. Infect. Dis."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nm0311-252","article-title":"A siege of hepatitis: immune boost for viral hepatitis","volume":"17","author":"Callendret","year":"2011","journal-title":"Nat. Med."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1172\/JCI200318509","article-title":"Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers","volume":"112","author":"Day","year":"2003","journal-title":"J. Clin. Invest."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0016-5085(99)70353-7","article-title":"Recurrence of hepatitis C virus after loss of virus-specific CD4+ T-cell response in acute hepatitis C","volume":"117","author":"Gerlach","year":"1999","journal-title":"Gastroenterology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1084\/jem.20100388","article-title":"Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence","volume":"209","author":"Schulze Zur Wiesch","year":"2012","journal-title":"J. Exp. Med."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.virol.2012.10.005","article-title":"NK cells controlling virus-specific T cells: rheostats for acute vs. persistent infections","volume":"435","author":"Welsh","year":"2013","journal-title":"Virology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1128\/JVI.03002-13","article-title":"Therapeutic depletion of natural killer cells controls persistent infection","volume":"88","author":"Waggoner","year":"2014","journal-title":"J. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/hep.23319","article-title":"Selection-driven immune escape is not a significant factor in the failure of CD4 T cell responses in persistent hepatitis C virus infection","volume":"51","author":"Fuller","year":"2010","journal-title":"Hepatology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1099\/vir.0.017699-0","article-title":"Virological footprint of CD4+ T-cell responses during chronic hepatitis C virus infection","volume":"91","author":"Fleming","year":"2010","journal-title":"J. Gen. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/hep.21365","article-title":"Loss of IL-7 receptor \u03b1-chain (CD127) expression in acute HCV infection associated with viral persistence","volume":"44","author":"Golden-Mason","year":"2006","journal-title":"Hepatology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1172\/JCI43127","article-title":"Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity","volume":"120","author":"McMahan","year":"2010","journal-title":"J. Clin. Invest."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1053\/j.gastro.2011.07.004","article-title":"Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection","volume":"141","author":"Raziorrouh","year":"2011","journal-title":"Gastroenterology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"e1003422","DOI":"10.1371\/journal.ppat.1003422","article-title":"Galectin-9 and IL-21 mediate cross-regulation between Th17 and Treg cells during acute hepatitis C","volume":"9","author":"Kared","year":"2013","journal-title":"PLoS Pathog."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"e1000947","DOI":"10.1371\/journal.ppat.1000947","article-title":"Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation","volume":"6","author":"Bengsch","year":"2010","journal-title":"PLoS Pathog."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1128\/JVI.02021-06","article-title":"Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression","volume":"81","author":"Radziewicz","year":"2007","journal-title":"J. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"9122","DOI":"10.1128\/JVI.00639-09","article-title":"Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells","volume":"83","author":"Golden-Mason","year":"2009","journal-title":"J. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1053\/j.gastro.2013.10.022","article-title":"Liver environment and HCV replication affect human T-cell phenotype and expression of inhibitory receptors","volume":"146","author":"Kroy","year":"2014","journal-title":"Gastroenterology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.immuni.2011.07.010","article-title":"CD8(+) T cells: foot soldiers of the immune system","volume":"35","author":"Zhang","year":"2011","journal-title":"Immunity"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.it.2011.01.004","article-title":"Cytokines and the inception of CD8 T cell responses","volume":"32","author":"Cox","year":"2011","journal-title":"Trends Immunol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"9808","DOI":"10.1128\/JVI.01075-08","article-title":"Impaired hepatitis C virus (HCV)-specific effector CD8+ T cells undergo massive apoptosis in the peripheral blood during acute HCV infection and in the liver during the chronic phase of infection","volume":"82","author":"Radziewicz","year":"2008","journal-title":"J. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1053\/j.gastro.2012.06.005","article-title":"Successful vaccination induces multifunctional memory T-cell precursors associated with early control of hepatitis C virus","volume":"143","author":"Park","year":"2012","journal-title":"Gastroenterology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"30ra32","DOI":"10.1126\/scitranslmed.3000544","article-title":"Rapid emergence of protease inhibitor resistance in hepatitis C virus","volume":"2","author":"Rong","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S1074-7613(01)00245-X","article-title":"The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes","volume":"15","author":"Erickson","year":"2001","journal-title":"Immunity"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1084\/jem.20041006","article-title":"CD8 epitope escape and reversion in acute HCV infection","volume":"200","author":"Timm","year":"2004","journal-title":"J. Exp. Med."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1084\/jem.20050121","article-title":"Cellular immune selection with hepatitis C virus persistence in humans","volume":"201","author":"Cox","year":"2005","journal-title":"J. Exp. Med."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1084\/jem.20042284","article-title":"Immune evasion versus recovery after acute hepatitis C virus infection from a shared source","volume":"201","author":"Tester","year":"2005","journal-title":"J. Exp. Med."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2893.2005.00676.x","article-title":"Do antiviral CD8+ T cells select hepatitis C virus escape mutants? Analysis in diverse epitopes targeted by human intrahepatic CD8+ T lymphocytes","volume":"13","author":"Komatsu","year":"2006","journal-title":"J. Viral Hepat."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/hep.21049","article-title":"Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution","volume":"43","author":"Neumann-Haefelin","year":"2006","journal-title":"Hepatology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1136\/gut.2010.228403","article-title":"Molecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection","volume":"60","author":"Fitzmaurice","year":"2011","journal-title":"Gut"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/hep.24076","article-title":"Effect of immune pressure on hepatitis C virus evolution: insights from a singlesource outbreak","volume":"53","author":"Merani","year":"2011","journal-title":"Hepatology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1084\/jem.20040638","article-title":"Limited T cell receptor diversity of HCV-specific T cell responses is associated with CTL escape","volume":"200","author":"Meyer-Olson","year":"2004","journal-title":"J. Exp. Med."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"6435","DOI":"10.4049\/jimmunol.181.9.6435","article-title":"Hepatitis C virus immune escape via exploitation of a hole in the T cell repertoire","volume":"181","author":"Wolfl","year":"2008","journal-title":"J. Immunol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1172\/JCI119778","article-title":"Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus","volume":"100","author":"Chang","year":"1997","journal-title":"J. Clin. Invest."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/1743-422X-10-295","article-title":"Lack of variant specific CD8+ T-cell response against mutant and pre-existing variants leads to outgrowth of particular clones in acute hepatitis C","volume":"10","author":"Ulsenheimer","year":"2013","journal-title":"Virol. J."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"9782","DOI":"10.1128\/JVI.78.18.9782-9789.2004","article-title":"Long-term persistence of infection in chimpanzees inoculated with an infectious hepatitis C virus clone is associated with a decrease in the viral amino acid substitution rate and low levels of heterogeneity","volume":"78","author":"Fernandez","year":"2004","journal-title":"J. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/gut.2005.072231","article-title":"Relation between viral fitness and immune escape within the hepatitis C virus protease","volume":"55","author":"Soderholm","year":"2006","journal-title":"Gut"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1099\/vir.0.82826-0","article-title":"Absence of viral escape within a frequently recognized HLA-A26-restricted CD8+ T-cell epitope targeting the functionally constrained hepatitis C virus NS5A\/5B cleavage site","volume":"88","author":"Neumann-Haefelin","year":"2007","journal-title":"J. Gen. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"e1000143","DOI":"10.1371\/journal.ppat.1000143","article-title":"Stable cytotoxic T cell escape mutation in hepatitis C virus is linked to maintenance of viral fitness","volume":"4","author":"Uebelhoer","year":"2008","journal-title":"PLoS Pathog."},{"key":"2023032708372924700_","first-page":"376","article-title":"Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response","volume":"119","author":"Dazert","year":"2009","journal-title":"J. Clin. Invest."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"e16797","DOI":"10.1371\/journal.pone.0016797","article-title":"Constrained pattern of viral evolution in acute and early HCV infection limits viral plasticity","volume":"6","author":"Pfafferott","year":"2011","journal-title":"PLoS One"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"11658","DOI":"10.1128\/JVI.00995-07","article-title":"Viral sequence evolution in acute hepatitis C virus infection","volume":"81","author":"Kuntzen","year":"2007","journal-title":"J. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/nm.3351","article-title":"Loss of immune escape mutations during persistent HCV infection in pregnancy enhances replication of vertically transmitted viruses","volume":"19","author":"Honegger","year":"2013","journal-title":"Nat. Med."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"7519","DOI":"10.4049\/jimmunol.175.11.7519","article-title":"The impairment of CD8 responses limits the selection of escape mutations in acute hepatitis C virus infection","volume":"175","author":"Urbani","year":"2005","journal-title":"J. Immunol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"8215","DOI":"10.4049\/jimmunol.181.12.8215","article-title":"High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection","volume":"181","author":"Rutebemberwa","year":"2008","journal-title":"J. Immunol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1128\/JVI.01499-09","article-title":"Hepatitis C virus (HCV) sequence variation induces an HCV-specific T-cell phenotype analogous to spontaneous resolution","volume":"84","author":"Kasprowicz","year":"2010","journal-title":"J. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1084\/jem.20121015","article-title":"Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice","volume":"209","author":"Frebel","year":"2012","journal-title":"J. Exp. Med."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.it.2012.12.002","article-title":"The risks of targeting co-inhibitory pathways to modulate pathogen-directed T cell responses","volume":"34","author":"Frebel","year":"2013","journal-title":"Trends Immunol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1128\/JVI.00060-08","article-title":"Variable patterns of programmed death-1 expression on fully functional memory T cells after spontaneous resolution of hepatitis C virus infection","volume":"82","author":"Bowen","year":"2008","journal-title":"J. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1053\/j.gastro.2008.02.033","article-title":"Functional restoration of HCV-specific CD8 T cells by PD-1 blockade Is defined by PD-1 expression and compartmentalization","volume":"134","author":"Nakamoto","year":"2008","journal-title":"Gastroenterology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"15001","DOI":"10.1073\/pnas.1312772110","article-title":"Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)","volume":"110","author":"Fuller","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"e1000313","DOI":"10.1371\/journal.ppat.1000313","article-title":"Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1\/CTLA-4 blockade","volume":"5","author":"Nakamoto","year":"2009","journal-title":"PLoS Pathog."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1086\/432478","article-title":"Humoral immune response in acute hepatitis C virus infection","volume":"41","author":"Netski","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.3851\/IMP2222","article-title":"Primary, post-primary and non-specific immunoglobulin M responses in HCV infection","volume":"17","author":"Dustin","year":"2012","journal-title":"Antivir. Ther."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1128\/JVI.73.2.1118-1126.1999","article-title":"Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees","volume":"73","author":"Bassett","year":"1999","journal-title":"J. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1074-7613(00)80044-8","article-title":"Analysis of a successful immune response against hepatitis C virus","volume":"10","author":"Cooper","year":"1999","journal-title":"Immunity"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1006\/clim.2001.5132","article-title":"Outcome of intravenous immunoglobulin-transmitted hepatitis C virus infection in primary immunodeficiency","volume":"101","author":"Razvi","year":"2001","journal-title":"Clin. Immunol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"10149","DOI":"10.1073\/pnas.0403519101","article-title":"Neutralizing antibody response during acute and chronic hepatitis C virus infection","volume":"101","author":"Logvinoff","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"6586","DOI":"10.1128\/JVI.76.13.6586-6595.2002","article-title":"Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge","volume":"76","author":"Major","year":"2002","journal-title":"J. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/75063","article-title":"Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C","volume":"6","author":"Takaki","year":"2000","journal-title":"Nat. Med."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1073\/pnas.0607026104","article-title":"Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C","volume":"104","author":"Pestka","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/j.gastro.2009.09.017","article-title":"Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection","volume":"138","author":"Osburn","year":"2010","journal-title":"Gastroenterology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"14199","DOI":"10.1073\/pnas.2335981100","article-title":"In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes","volume":"100","author":"Bartosch","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1053\/j.gastro.2006.11.044","article-title":"Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 T-cell responses in acute hepatitis C","volume":"132","author":"Kaplan","year":"2007","journal-title":"Gastroenterology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"7792","DOI":"10.1073\/pnas.91.16.7792","article-title":"Prevention of hepatitis C virus infection in chimpanzee after antibody-mediated in vitro neutralization","volume":"91","author":"Farci","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"7705","DOI":"10.1073\/pnas.0402458101","article-title":"Neutralizing antibodies to hepatitis C virus (HCV) in immune globulins derived from anti-HCV-positive plasma","volume":"101","author":"Yu","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1002\/hep.22244","article-title":"Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain","volume":"47","author":"Vanwolleghem","year":"2008","journal-title":"Hepatology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/jvh.12094","article-title":"Virus-neutralizing antibodies to hepatitis C virus","volume":"20","author":"Wahid","year":"2013","journal-title":"J. Viral. Hepat."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"8449","DOI":"10.1073\/pnas.0703039104","article-title":"Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma","volume":"104","author":"Zhang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"7537","DOI":"10.1073\/pnas.0902749106","article-title":"Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1128\/JVI.01941-12","article-title":"Cooperativity in virus neutralization by human monoclonal antibodies to two adjacent regions located at the amino terminus of hepatitis C virus E2 glycoprotein","volume":"87","author":"Keck","year":"2013","journal-title":"J. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"12686","DOI":"10.1128\/JVI.00994-12","article-title":"Amino acid residue-specific neutralization and nonneutralization of hepatitis C virus by monoclonal antibodies to the E2 protein","volume":"86","author":"Duan","year":"2012","journal-title":"J. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.3390\/v3101909","article-title":"The hepatitis C virus glycan shield and evasion of the humoral immune response","volume":"3","author":"Helle","year":"2011","journal-title":"Viruses"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"9505","DOI":"10.1073\/pnas.1307527110","article-title":"Ultrastructural analysis of hepatitis C virus particles","volume":"110","author":"Catanese","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/hep.21959","article-title":"Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies","volume":"47","author":"Timpe","year":"2008","journal-title":"Hepatology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1053\/j.gastro.2009.07.050","article-title":"Visualizing hepatitis C virus infections in human liver by two-photon microscopy","volume":"137","author":"Liang","year":"2009","journal-title":"Gastroenterology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/JVI.01592-10","article-title":"Neutralizing antibody-resistant hepatitis C virus cell-to-cell transmission","volume":"85","author":"Brimacombe","year":"2011","journal-title":"J. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"13109","DOI":"10.1073\/pnas.1221899110","article-title":"Exosome-mediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells","volume":"110","author":"Ramakrishnaiah","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"8282","DOI":"10.1128\/JVI.01102-13","article-title":"Different requirements for scavenger receptor class B type I in hepatitis C virus cell-free versus cell-to-cell transmission","volume":"87","author":"Catanese","year":"2013","journal-title":"J. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1128\/JVI.02200-09","article-title":"Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes","volume":"84","author":"Bankwitz","year":"2010","journal-title":"J. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.01594-10","article-title":"Hypervariable region 1 differentially impacts viability of hepatitis C virus strains of genotypes 1 to 6 and impairs virus neutralization","volume":"85","author":"Prentoe","year":"2011","journal-title":"J. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/j.gastro.2006.12.008","article-title":"Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo","volume":"132","author":"von Hahn","year":"2007","journal-title":"Gastroenterology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1053\/j.gastro.2009.02.080","article-title":"Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus","volume":"136","author":"Dowd","year":"2009","journal-title":"Gastroenterology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"5067","DOI":"10.1128\/JVI.02265-09","article-title":"Acceleration of hepatitis C virus envelope evolution in humans is consistent with progressive humoral immune selection during the transition from acute to chronic infection","volume":"84","author":"Liu","year":"2010","journal-title":"J. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/hep.510270134","article-title":"Comparison of the rate of sequence variation in the hypervariable region of E2\/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients","volume":"27","author":"Booth","year":"1998","journal-title":"Hepatology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1086\/432917","article-title":"Reemergence of hepatitis C virus after 8.5 years in a patient with hypogammaglobulinemia: evidence for an occult viral reservoir","volume":"192","author":"Lee","year":"2005","journal-title":"J. Infect. Dis."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/jmv.10296","article-title":"Changes in hypervariable region 1 of the envelope 2 glycoprotein of hepatitis C virus in children and adults with humoral immune defects","volume":"69","author":"Gaud","year":"2003","journal-title":"J. Med. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1126\/science.1243876","article-title":"Hepatitis C virus E2 envelope glycoprotein core structure","volume":"342","author":"Kong","year":"2013","journal-title":"Science"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"8400","DOI":"10.1128\/JVI.79.13.8400-8409.2005","article-title":"Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins","volume":"79","author":"Goffard","year":"2005","journal-title":"J. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"11905","DOI":"10.1128\/JVI.01548-10","article-title":"Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions","volume":"84","author":"Helle","year":"2010","journal-title":"J. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"8072","DOI":"10.1128\/JVI.00459-07","article-title":"Hepatitis C virus envelope glycoprotein E2 glycans modulate entry, CD81 binding, and neutralization","volume":"81","author":"Falkowska","year":"2007","journal-title":"J. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"8101","DOI":"10.1128\/JVI.00127-07","article-title":"The neutralizing activity of anti-hepatitis C virus antibodies is modulated by specific glycans on the E2 envelope protein","volume":"81","author":"Helle","year":"2007","journal-title":"J. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00000441-200303000-00006","article-title":"Extrahepatic manifestations of hepatitis C infection","volume":"325","author":"Mayo","year":"2003","journal-title":"Am. J. Med. Sci."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1001\/jama.297.18.2010","article-title":"Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus","volume":"297","author":"Giordano","year":"2007","journal-title":"JAMA"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/ki.2009.247","article-title":"Hepatitis C virus-induced cryoglobulinemia","volume":"76","author":"Charles","year":"2009","journal-title":"Kidney Int."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0140-6736(11)60242-0","article-title":"The cryoglobulinaemias","volume":"379","author":"Ramos-Casals","year":"2012","journal-title":"Lancet"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jhep.2013.03.018","article-title":"Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management","volume":"59","author":"Peveling-Oberhag","year":"2013","journal-title":"J. Hepatol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1182\/blood-2007-07-101717","article-title":"Clonal expansion of IgM + CD27+ B cells in HCV-associated mixed cryoglobulinemia","volume":"111","author":"Charles","year":"2008","journal-title":"Blood"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.autrev.2012.08.016","article-title":"Clonal expansion and functional exhaustion of monoclonal marginal zone B cells in mixed cryoglobulinemia: the yin and yang of HCV-driven lymphoproliferation and autoimmunity","volume":"12","author":"Visentini","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1182\/blood-2010-10-312942","article-title":"Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset","volume":"117","author":"Charles","year":"2011","journal-title":"Blood"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1182\/blood.V97.4.1023","article-title":"V(H)1\u201369 gene is preferentially used by hepatitis C virus-associated B cell lymphomas and by normal B cells responding to the E2 viral antigen","volume":"97","author":"Chan","year":"2001","journal-title":"Blood"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0002-9440(10)61691-4","article-title":"Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma","volume":"159","author":"Marasca","year":"2001","journal-title":"Am. J. Pathol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/1097-0215(20000715)87:2<211::AID-IJC9>3.0.CO;2-8","article-title":"Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process","volume":"87","author":"De Re","year":"2000","journal-title":"Intl. J. Cancer"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.4049\/jimmunol.1102022","article-title":"Expansion of functionally anergic CD21-\/low marginal zone-like B cell clones in hepatitis C virus infection-related autoimmunity","volume":"187","author":"Terrier","year":"2011","journal-title":"J. Immunol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1182\/blood.V91.7.2433","article-title":"Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1\/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas","volume":"91","author":"Ivanovski","year":"1998","journal-title":"Blood"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"18544","DOI":"10.1073\/pnas.0509402102","article-title":"Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders","volume":"102","author":"Rosa","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1128\/JVI.77.3.2134-2146.2003","article-title":"Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection","volume":"77","author":"Sung","year":"2003","journal-title":"J. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1002\/hep.22550","article-title":"Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells","volume":"48","author":"Marukian","year":"2008","journal-title":"Hepatology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"8496","DOI":"10.1128\/JVI.78.16.8496-8505.2004","article-title":"Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81 dependent manner","volume":"78","author":"McKeating","year":"2004","journal-title":"J. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1086\/514114","article-title":"Detection of hepatitis C virus RNA in CD19 peripheral blood mononuclear cells of chronically infected patients","volume":"176","author":"Zehender","year":"1997","journal-title":"J. Infect. Dis."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1099\/0022-1317-79-4-705","article-title":"Low level or absent in vivo replication of hepatitis C virus and hepatitis G virus\/GB virus C in peripheral blood mononuclear cells","volume":"79","author":"Mellor","year":"1998","journal-title":"J. Gen. Virol."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1053\/j.gastro.2007.12.011","article-title":"Hepatitis C virus replicates in the same immune cell subsets in chronic hepatitis C and occult infection","volume":"134","author":"Pham","year":"2008","journal-title":"Gastroenterology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1053\/j.gastro.2010.10.048","article-title":"Sporadic reappearance of minute amounts of hepatitis C virus RNA after successful therapy stimulates cellular immune responses","volume":"140","author":"Veerapu","year":"2011","journal-title":"Gastroenterology"},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/art.38041","article-title":"Somatic hypermutations confer rheumatoid factor activity in hepatitis C virus-associated mixed cryoglobulinemia","volume":"65","author":"Charles","year":"2013","journal-title":"Arthritis Rheum."},{"key":"2023032708372924700_","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/rheumatology\/kel177","article-title":"Hepatitis C virus-associated B-cell proliferation\u2014the role of serum B lymphocyte stimulator (BLyS\/BAFF)","volume":"46","author":"S\u00e8ne","year":"2007","journal-title":"Rheumatology (Oxford)"}],"container-title":["Journal of Leukocyte Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1189%2Fjlb.4RI0214-126R","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/96\/4\/535\/49579635\/jlb0535.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/96\/4\/535\/49579635\/jlb0535.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T06:02:19Z","timestamp":1689400939000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jleukbio\/article\/96\/4\/535\/6959386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,11]]},"references-count":223,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,7,11]]},"published-print":{"date-parts":[[2014,7,11]]}},"URL":"https:\/\/doi.org\/10.1189\/jlb.4ri0214-126r","relation":{},"ISSN":["0741-5400","1938-3673"],"issn-type":[{"value":"0741-5400","type":"print"},{"value":"1938-3673","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,10]]},"published":{"date-parts":[[2014,7,11]]}}}